{"database": "lobbying", "table": "lobbying_activities", "rows": [[1948771, "b38b497b-7287-45b6-bcb8-6eeb203d38a3", "Q1", "RED+BLUE STRATEGIES", 400693064, "EXPRESS SCRIPTS INC.", 2017, "first_quarter", "MMM", "S. 637 - Creating Transparency to have Prescription Drug Rebates Unlocked - Issues related to the alleged relationship between rebates and drug prices.\n\nS. 771 - A bill to Improve Access to Affordable Prescription Drugs - Issue related to bringing drug pricing down including better policies in the Part D coverage gap, couponing and advancing biosimilars.", "Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2017-04-05T11:14:18.410000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1948771"], "units": {}, "query_ms": 0.36780498339794576, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}